12:04 PM
 | 
Sep 06, 2018
 |  BC Extra  |  Financial News

Liquid biopsy company Guardant files for NASDAQ IPO

Guardant Health Inc. (Redwood City, Calif.) filed to raise up to $100 million in an IPO on NASDAQ underwritten by J.P. Morgan, BofA Merrill Lynch, Cowen, Leerink and William Blair.

The liquid biopsy company’s last venture round came in May 2017, when it raised $360 million in a series E...

Read the full 226 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >